CareLit Fachartikel
The CDK4/6 inhibitor Palbociclib and the mTOR inhibitor MLN0128 are effective for the treatment of experimental intrahepatic cholangiocarcinoma
X Chen, M Evert, F Dombrowski, S Ribback, X Liu, X Song, K Utpatel, D Calvisi · Zeitschrift für Gastroenterologie · 2018 · Heft 01
Dokument
1188010
CareLit-ID
Jahr
2018
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
The CDK4/6 inhibitor Palbociclib and the mTOR inhibitor MLN0128 are effective for the treatment of experimental intrahepatic cholangiocarcinoma
Schlagworte
Cholangiocarcinoma
Zeitschrift für Gastroenterologie